Louis Pena is the founder of Evommune. Evommune has raised $115M in total funding. Latest round: Series C. Based in Palo Alto, United States.
Luis Peña is the Co-Founder, President, Chief Executive Officer, and a board member of Evommune, a clinical-stage biotechnology company focused on treating immune-mediated inflammatory diseases. With over 30 years of experience in biotech and pharmaceuticals, he previously co-founded Dermira, leading its R&D group until its acquisition by Eli Lilly & Company for $1.1 billion. Evommune recently completed a $115 million Series C financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library